Literature DB >> 33499822

The Association of Metabolic Syndrome with the development of cardiovascular disease among Kazakhs in remote rural areas of Xinjiang, China: a cohort study.

Wenwen Yang1, Shuxia Guo1, Haixia Wang1, Yu Li1, Xianghui Zhang1, Yunhua Hu1, Heng Guo1, Kui Wang1, Yizhong Yan1, Jingyu Zhang1, Jiaolong Ma1, Lei Mao1, Lati Mu1, Jiaming Liu1, Yanpeng Song1, Changjing Li1, Zhuo Ma1, Rulin Ma2, Jia He3.   

Abstract

BACKGROUND: Metabolic syndrome (MS) can promote the development of cardiovascular disease (CVD). The objective of this study was to examine the association of MS and its components with CVD, to further prevent and control CVD in Kazakhs.
METHODS: In the cohort study, a total of 2644 participants completed the baseline survey between April 2010 and December 2012.The follow-up survey was conducted from April 2016 to December 2016 and was completed by 2286 participants (86.46% follow-up rate). Cox regression was used to evaluate the association of each component and the number of combinations of MS components on the development of CVD.
RESULTS: A total of 278 CVD patients were enrolled from rural residents of Xinjiang. The average age of the MS and non-MS groups was 46.33 and 38.71 years, respectively. Independent associations with CVD were found for elevated blood pressure (BP) (adjusted hazard ratio (HR) [aHR] = 1.50,95%confidence interval [CI]: 1.08-2.08), elevated waist circumference (WC) (aHR = 1.60, 95%CI: 1.19-2.15), and elevated triglycerides (TG) (aHR = 1.44, 95%CI: 1.04-2.01). Participants with one to 5 MS components had an increased HR for developing CVD, from 1.82to 8.59 (P for trend < 0.001), compared with those with no MS components. The risk of developing CVD increased when TG and WC coexisted (aHR = 2.16, 95%CI: 1.54-3.04)), when TG and BP coexisted ((aHR = 1.92, 95%CI: 1.32-2.79), and when WC and BP coexisted (aHR = 1.93, 95%CI: 1.33-2.82)). However, no significant interactions were found between BP, WC, and TG.
CONCLUSIONS: Elevations of BP, WC, and TG were independent risk factors for CVD in Kazakhs. Control of these factors is important to prevent CVD in this population.

Entities:  

Keywords:  Cardiovascular disease; Kazakhs; Metabolic syndrome

Mesh:

Year:  2021        PMID: 33499822      PMCID: PMC7836449          DOI: 10.1186/s12889-021-10241-w

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  32 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  [Epidemiological study on overweight and obesity among rural adult residents in Hazakh and Uygur population in Xinjiang province, 2010].

Authors:  Jia He; Heng Guo; Jing-yu Zhang; Yu-song Ding; Jia-ming Liu; Mei Zhang; Ru-lin Ma; Shu-gang Li; Feng Sun; Shang-zhi Xu; Shu-xia Guo
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2013-10

3.  The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.

Authors:  P Alaupovic; W J Mack; C Knight-Gibson; H N Hodis
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-04       Impact factor: 8.311

Review 4.  Triglycerides and cardiovascular disease.

Authors:  Børge G Nordestgaard; Anette Varbo
Journal:  Lancet       Date:  2014-08-16       Impact factor: 79.321

5.  Major causes of death among men and women in China.

Authors:  Jiang He; Dongfeng Gu; Xigui Wu; Kristi Reynolds; Xiufang Duan; Chonghua Yao; Jialiang Wang; Chung-Shiuan Chen; Jing Chen; Rachel P Wildman; Michael J Klag; Paul K Whelton
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

6.  Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study.

Authors:  G Neil Thomas; C Mary Schooling; Sarah M McGhee; Sai-Yin Ho; Bernard M Y Cheung; Nelson M S Wat; Edward D Janus; Karen S L Lam; Tai Hing Lam
Journal:  Clin Endocrinol (Oxf)       Date:  2007-03-23       Impact factor: 3.478

7.  Blood pressure has a greater impact on cardiovascular mortality than other components of metabolic syndrome in Koreans.

Authors:  Chan Yim Shin; Kyung Eun Yun; Hye Soon Park
Journal:  Atherosclerosis       Date:  2009-01-21       Impact factor: 5.162

8.  Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study.

Authors:  Johan Sundström; Ulf Risérus; Liisa Byberg; Björn Zethelius; Hans Lithell; Lars Lind
Journal:  BMJ       Date:  2006-03-01

9.  Sex factors in the metabolic syndrome as a predictor of cardiovascular disease.

Authors:  Sunghwan Suh; Jongha Baek; Ji Cheol Bae; Kyoung Nyoun Kim; Mi Kyoung Park; Duk Kyu Kim; Nam H Cho; Moon Kyu Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2014-12-29

10.  Metabolic Syndrome and Framingham Risk Score: Observation from Screening of Low-Income Semi-Urban African Women.

Authors:  Ayokunle S Dada; Daisi D Ajayi; Peter O Areo; Taiwo H Raimi; Eyitayo E Emmanuel; Olusola O Odu; Olusegun A Aremu
Journal:  Medicines (Basel)       Date:  2016-06-09
View more
  1 in total

1.  Comparison of the Incidence of Cardiovascular Diseases in Weight Groups with Healthy and Unhealthy Metabolism.

Authors:  Wenqiang Wang; Jia He; Yunhua Hu; Yanpeng Song; Xianghui Zhang; Heng Guo; Xinping Wang; Mulatibieke Keerman; Jiaolong Ma; Yizhong Yan; Jingyu Zhang; Rulin Ma; Shuxia Guo
Journal:  Diabetes Metab Syndr Obes       Date:  2021-10-01       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.